NEU 1.06% $18.65 neuren pharmaceuticals limited

Difficult to know whether Davis was intimating that Acadia has...

  1. 5,766 Posts.
    lightbulb Created with Sketch. 16249
    Difficult to know whether Davis was intimating that Acadia has acquired full rights to NNZ-2591 or if he simply failed to make clear that the NNZ-2591 rights acquired by Acadia are limited to Rett syndrome and Fragile-X.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$18.65
Change
-0.200(1.06%)
Mkt cap ! $2.381B
Open High Low Value Volume
$18.85 $18.92 $18.35 $10.53M 566.6K

Buyers (Bids)

No. Vol. Price($)
1 45 $18.64
 

Sellers (Offers)

Price($) Vol. No.
$18.73 1500 1
View Market Depth
Last trade - 16.10pm 26/04/2024 (20 minute delay) ?
Last
$18.73
  Change
-0.200 ( 0.73 %)
Open High Low Volume
$18.89 $18.89 $18.36 91292
Last updated 15.59pm 26/04/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.